[1] BRONZATO JD, DAVIDIAN MES, DE CASTRO M, et al. Bacteria and virulence factors in periapical lesions associated with teeth following primary and secondary root canal treatment. Int Endod J. 2021;54(5):660-671.
[2] 刘大勇,王梅蕊,兰玲玲,等.脂多糖干预卵巢切除小鼠骨髓间充质干细胞的成骨分化能力[J].中国组织工程研究,2014,18(14):2219-2225.
[3] 余科,吴湘楠,刘文佳,等. LPS刺激小鼠骨细胞RANKL/OPG和IL-6表达的实验研究[J].口腔医学研究,2016(3):220-223.
[4] YU K, MA Y, LI X, et al. Lipopolysaccharide increases IL-6 secretion via activation of the ERK1/2 signaling pathway to up-regulate RANKL gene expression in MLO-Y4 cells. Cell Biol Int. 2017;41(1):84-92.
[5] GALARRAGA-VINUEZA ME, DOHLE E, RAMANAUSKAITE A, et al. Anti-inflammatory and macrophage polarization effects of Cranberry Proanthocyanidins (PACs) for periodontal and peri-implant disease therapy. J Periodontal Res. 2020;55(6):821-829.
[6] LI G, LIU Y, MENG F, et al. LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway. J Cell Mol Med. 2019; 23(10):7116-7120.
[7] ZHAO X, ALQWBANI M, LUO Y, et al. Glucocorticoids decreased Cx43 expression in osteonecrosis of femoral head: The effect on proliferation and osteogenic differentiation of rat BMSCs. J Cell Mol Med. 2021;25(1):484-498.
[8] KITAURA H, MARAHLEH A, OHORI F, et al. Osteocyte-Related Cytokines Regulate Osteoclast Formation and Bone Resorption. Int J Mol Sci. 2020;21(14):5169.
[9] FENG W, GUO J, LI M. RANKL-independent modulation of osteoclastogenesis. J Oral Biosci. 2019;61(1):16-21.
[10] AMIN N, BOCCARDI V, TAGHIZADEH M, et al. Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway. Aging Clin Exp Res. 2020;32(3):363-371.
[11] Martin TJ, Sims NA. RANKL/OPG; Critical role in bone physiology. Rev Endocr Metab Disord. 2015;16(2):131-139.
[12] JIANG J, JIA Y, LU X, et al. Vitexin suppresses RANKL-induced osteoclastogenesis and prevents lipopolysaccharide (LPS)-induced osteolysis. J Cell Physiol. 2019; 234(10):17549-17560.
[13] FANG L, WANG KK, HUANG Q, et al. Nucleolin Mediates LPS-induced Expression of Inflammatory Mediators and Activation of Signaling Pathways. Curr Med Sci. 2020;40(4):646-653.
[14] CHAE BS. Pretreatment of Low-Dose and Super-Low-Dose LPS on the Production of In Vitro LPS-Induced Inflammatory Mediators. Toxicol Res. 2018;34(1):65-73.
[15] LEE GL, YEH CC, WU JY, et al. TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction. Arterioscler Thromb Vasc Biol. 2019;39(3):432-445.
[16] KIM HJ, KIM HJ, CHOI Y, et al. Zoledronate Enhances Osteocyte-Mediated Osteoclast Differentiation by IL-6/RANKL Axis. Int J Mol Sci. 2019;20(6):1467.
[17] MCGREGOR NE, MURAT M, ELANGO J, et al. IL-6 exhibits both cis- and trans-signaling in osteocytes and osteoblasts, but only trans-signaling promotes bone formation and osteoclastogenesis. J Biol Chem. 2019;294(19):7850-7863.
[18] BEZERRA MÉS, BARBERINO RS, MENEZES VG, et al. Insulin-like growth factor-1 (IGF-1) promotes primordial follicle growth and reduces DNA fragmentation through the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) signalling pathway. Reprod Fertil Dev. 2018;30(11):1503-1513.
[19] DENG S, DAI G, CHEN S, et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomed Pharmacother. 2019;110:602-608.
[20] MA Y, RAN D, ZHAO H, et al. Cadmium exposure triggers osteoporosis in duck via P2X7/PI3K/AKT-mediated osteoblast and osteoclast differentiation. Sci Total Environ. 2021;750:141638.
[21] DA Y, MOU Y, WANG M, et al. Mechanical stress promotes biological functions of C2C12 myoblasts by activating PI3K/AKT/mTOR signaling pathway. Mol Med Rep. 2020;21(1):470-477.
[22] SONG F, WANG Y, JIANG D, et al. Cyclic Compressive Stress Regulates Apoptosis in Rat Osteoblasts: Involvement of PI3K/Akt and JNK MAPK Signaling Pathways. PLoS One. 2016;11(11):e0165845.
[23] LI ST, DAI Q, ZHANG SX, et al. Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway. Acta Pharmacol Sin. 2018; 39(8):1294-1304.
[24] ZHONG Z, CHEN A, FA Z, et al. Bone marrow mesenchymal stem cells upregulate PI3K/AKT pathway and down-regulate NF-κB pathway by secreting glial cell-derived neurotrophic factors to regulate microglial polarization and alleviate deafferentation pain in rats. Neurobiol Dis. 2020;143:104945.
[25] PROSSOMARITI A, PIAZZI G, ALQUATI C, et al. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer? Cell Mol Gastroenterol Hepatol. 2020;10(3):491-506.
[26] YAN L, LU L, HU F, et al. Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts. R Soc Open Sci. 2019;6(6):190360.
[27] BONEWALD LF. Establishment and characterization of an osteocyte-like cell line, MLO-Y4. J Bone Miner Metab. 1999;17(1): 61-65.
[28] LIN CN, DING SJ, CHEN CC. Synergistic Photoantimicrobial Chemotherapy of Methylene Blue-Encapsulated Chitosan on Biofilm-Contaminated Titanium. Pharmaceuticals (Basel). 2021;14(4):346.
[29] DOUGALL WC, GLACCUM M, CHARRIER K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999;13(18):2412-2424.
[30] MARAHLEH A, KITAURA H, OHORI F, et al. TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation. Front Immunol. 2019;10: 2925.
[31] KIM HN, XIONG J, MACLEOD RS, et al. Osteocyte RANKL is required for cortical bone loss with age and is induced by senescence. JCI Insight. 2020;5(19):e138815.
[32] UCHIBORI S, SEKIYA T, SATO T, et al. Suppression of tooth movement-induced sclerostin expression using β-adrenergic receptor blockers. Oral Dis. 2020;26(3): 621-629.
[33] ALQRANEI MS, CHELLAIAH MA. Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms. J Oral Biosci. 2020;62(2):123-130.
[34] TERAMACHI J, INAGAKI Y, SHINOHARA H, et al. PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivo. Oral Dis. 2017; 23(2):181-188.
[35] MENDOZA MC, ER EE, BLENIS J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36(6):320-328.
[36] EVANGELISTI C, CHIARINI F, CAPPELLINI A, et al. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia. J Cell Physiol. 2020;235(6):5413-5428.
[37] DE SANTIS MC, GULLUNI F, CAMPA CC, et al. Targeting PI3K signaling in cancer: Challenges and advances. Biochim Biophys Acta Rev Cancer. 2019;1871(2):361-366.
[38] JOHNSON GE, IVANOV VN, HEI TK. Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis. 2008;13(6):790-802.
[39] XIE Y, SHI X, SHENG K, et al. PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med Rep. 2019;19(2):783-791.
[40] SUN K, LUO J, GUO J, et al. The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020;28(4):400-409.
[41] MANNING BD, TOKER A. AKT/PKB Signaling: Navigating the Network. Cell. 2017; 169(3):381-405.
[42] CHEN H, ZHOU L, WU X, et al. The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark Ed). 2016;21:1084-1091.
[43] BAI L, GAO J, WEI F, et al. Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes. Front Pharmacol. 2018;9:423.
[44] HOARE A, SOTO C, ROJAS-CELIS V, et al. Chronic Inflammation as a Link between Periodontitis and Carcinogenesis. Mediators Inflamm. 2019;2019:1029857.
|